Patents by Inventor Charl Se PARK

Charl Se PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant transition vector for increasing foreign protein expression
    Patent number: 11655482
    Abstract: Disclosed are a novel recombinant transition vector for increasing expression of a foreign protein in a native form without fusion partners, and a method for mass production of a foreign target protein using the same. The recombinant transition vector according to the present disclosure may allow a large amount of a foreign target protein with a high therapeutic and prophylactic value to be expressed in an insect cell. In particular, the vector may increase the expression of the foreign target protein in an own form thereof, not fused with other fusion partners. Therefore, the use of the recombinant transition vector may produce useful proteins such as antigens in insect cells at low cost and high efficiency.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: May 23, 2023
    Assignees: OPTIPHARM CO., LTD, CHUNGBUK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
    Inventors: Soo Dong Woo, Ji Hoon Lee, Won Seok Gwak, Ji In Ma, Beom Ku Han, Hyun Il Kim, Charl Se Park, Jae Bang Choi
  • RECOMBINANT TRANSITION VECTOR FOR INCREASING FOREIGN PROTEIN EXPRESSION
    Publication number: 20200291426
    Abstract: Disclosed are a novel recombinant transition vector for increasing expression of a foreign protein in a native form without fusion partners, and a method for mass production of a foreign target protein using the same. The recombinant transition vector according to the present disclosure may allow a large amount of a foreign target protein with a high therapeutic and prophylactic value to be expressed in an insect cell. In particular, the vector may increase the expression of the foreign target protein in an own form thereof, not fused with other fusion partners. Therefore, the use of the recombinant transition vector may produce useful proteins such as antigens in insect cells at low cost and high efficiency.
    Type: Application
    Filed: March 7, 2018
    Publication date: September 17, 2020
    Inventors: Soo Dong WOO, Ji Hoon LEE, Won Seok GWAK, Ji In MA, Beom Ku HAN, Hyun Il KIM, Charl Se PARK, Jae Bang CHOI